Overview

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Status:
Not yet recruiting

Trial end date:
2028-03-01

Target enrollment:

Participant gender:

Summary

To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer. The safety and effects of this study treatment will also be studied

Phase:

Phase 1

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

GlaxoSmithKline

Treatments:

Carboplatin
Cisplatin
Paclitaxel